New cutting edge technology can be used to grade cancer tumours, eradicating human subjectivity and ensuring patients get the right treatment.
A new imaging technology to grade tumour biopsies has been developed by a team of scientists led by the Department of Physics and the Department of Surgery and Cancer at Imperial College London.
Publishing their results today in the journal Convergent Science Physical Oncology, they describe how their new method promises to significantly reduce the subjectivity and variability in grading the severity of cancers.
[Digistain] is an extremely reliable indicator of the degree of progression of the disease. Because it is based on a physical measurement, rather than a human judgement, it promises to remove the element of chance in cancer diagnosis.Professor Chris Phillips
Nearly all cancers are still diagnosed by doctors taking a sample of the tumour, a so-called biopsy, then slicing it thinly and staining it with two vegetable dyes used for more than 100 years. They look at this ‘H+E stained’ sample under a microscope and then judge the severity of the disease by eye alone.
Life-changing treatment decisions have to be based on this ‘grading’ process, yet it is well known that different practitioners given the same slice will only agree on its grade about 70% of the time, resulting in an overtreatment problem.
The team’s new ‘Digistain’ technology addresses this problem by using invisible mid-infrared light to photograph the tissue slices in a way that maps out the chemical changes that signal the onset of cancer. In particular, they measure the ‘nuclear-to-cytoplasmic-ratio’ (NCR): a recognized biological marker for a wide range of cancers.
Lead author Professor Chris Phillips, from the Department of Physics at Imperial, said: “Our machine gives a quantitative ‘Digistain index’ (DI) score, corresponding to the NCR, and this study shows that it is an extremely reliable indicator of the degree of progression of the disease. Because it is based on a physical measurement, rather than a human judgement, it promises to remove the element of chance in cancer diagnosis. “
In the experiment reported today, the team carried out a double-blind clinical pilot trial using two adjacent slices taken from 75 breast cancer biopsies. The first slice was graded by clinicians as usual, using the standard H+E protocol. It was also used to identify the so-called ‘region of interest’ (RoI), i.e. the part of the slice containing the tumour.
The team then used the Digistain imager to get a DI value averaged over the corresponding RoI on the other, unstained slice, and ran a statistical analysis on the results.
Professor Phillips said: “Even with this modest number of samples, the correlation we saw between the DI score and the H+E grade would only happen by chance 1 time in 1400 trials. The strength of this correlation makes us extremely optimistic that Digistain will be able to eliminate subjectivity and variability in biopsy grading.”
Proving its worth
The NCR factor that Digistain measures is known to be common to a wide range of cancers, as it occurs when the reproductive cell cycle gets disrupted in the tumour and cell nuclei get distorted with rogue DNA. It is likely that in the long run, Digistain could help with the diagnosis of all different types of cancer.
At a practical level, the researchers say that the Digistain imaging technology can easily and cheaply be incorporated into existing hospital labs, and be used by their staff. Professor Philips added: “It’s easy to prove its worth by checking it with the thousands of existing biopsy specimens that are already held in hospital archives. Together these facts will smooth the path into the clinic, and it could be saving lives in only a couple of years.”
The Latest on: Cancer diagnosis
via Google News
The Latest on: Cancer diagnosis
- Christmas Island’s Kentwell family stranded in Perth after son Benji’s shock cancer diagnosison November 29, 2020 at 10:12 am
An unexpected trip to the doctor for their youngest son has left a Christmas Island family reeling, after a short Perth holiday quickly turned into their worst nightmare.
- ‘All My Life’ star Jessica Rothe inspired by true story of couple who moved up wedding after groom’s cancer diagnosison November 29, 2020 at 6:00 am
Actress Jessica Rothe stars in "All My Life," about a couple forced to move up their wedding date after the groom is diagnosed with terminal cancer.
- Bowel cancer symptoms: Polyps can develop into the deadly disease - what are they?on November 29, 2020 at 2:25 am
BOWEL cancer is the second biggest cancer killer in the UK; the deadly disease predominately affects people over the age of 50. However, early detection can lead to successful treatment and cure.
- Two thousand pancreatic cancer patients die in lockdownon November 29, 2020 at 2:09 am
Pancreatic referrals also fell by 80 percent. Ali Stunt, Founder of Pancreatic Cancer Action said: “Reduced referrals, delays in diagnosis and cancelled surgeries will almost certainly reverse ...
- A veteran's service dog helped her during her recovery from cancer. Now she's helping him with a similar diagnosison November 27, 2020 at 2:58 pm
"I was diagnosed with stage 3A breast cancer. I was 27 years old. I didn’t have anyone else in my family who had been through that. I remember one day I knew for sure that it was my last day. I knew ...
- Covid is masking the symptoms of deadliest cancer in UK – the 10 signs you must never ignoreon November 27, 2020 at 5:10 am
COVID-19 is masking the symptoms of the deadliest cancer in UK, experts say. Lung cancer, which kills more than 35,300 Brits a year, has very similar characteristics to the coronavirus. The most ...
- ‘Molecular clock’ blood test could help identify actively growing tumors in metastatic breast canceron November 26, 2020 at 9:39 pm
A blood test to watch breast cancer’s ‘molecular clock’ could help track the growth of multiple tumors around the body and monitor how they are responding to treatment, new research suggests.
- Corpus Christi grandparents won custody of three kids. Then came the cancer diagnosis.on November 26, 2020 at 5:04 am
Ben and Marie took in their three grandchildren. But a cancer diagnosis and financial troubles mean they need help for the holidays.
- Exercise found to reduce menopausal symptoms in cancer survivorson November 26, 2020 at 4:48 am
Physical activity can reduce the severity of early menopausal symptoms in women who have had cancer treatment, a University of Queensland study has found.
via Bing News